Xinhong Guo
Xinjiang Medical University(CN)First Affiliated Hospital of Xinjiang Medical University(CN)Bozhou People's Hospital(CN)People's Hospital of Xinjiang Uygur Autonomous Region(CN)Xinjiang Uygur Autonomous Region Uygur Medicine Hospital(CN)Shanghai University of Medicine and Health Sciences(CN)Institute of Coal Chemistry(CN)Wuhan University of Science and Technology(CN)
Publications by Year
Research Areas
Platelet Disorders and Treatments, Blood groups and transfusion, Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Chinese guidelines for treatment of adult primary immune thrombocytopenia(2018)76 cited
- → High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial(2020)59 cited
- → PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients(2019)55 cited
- → Regulation of Th1/Th2 and Th17/Treg by pDC/mDC imbalance in primary immune thrombocytopenia(2021)39 cited
- → Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study(2024)26 cited
- → Polymorphic Variation of Inflammation-related Genes and Risk of Non-Hodgkin Lymphoma for Uygur and Han Chinese in Xinjiang